<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<dataset>
    <author>Maciel, Belen Jesus</author>
    <author>Reigada, Chantal</author>
    <author>Di Girolamo, Fabio Augusto</author>
    <author>Rengifo Carrillo, Marcos Ramón</author>
    <author>Pereira, Claudio Alejandro</author>
    <author>Miranda, Mariana Reneé</author>
    <author>Martínez Sayé, Melisa Soledad</author>
    <fecha>2025</fecha>
    <handle>11336/256543</handle>
    <idioma>spa</idioma>
    <relationtype>https://doi.org/10.3389/fmicb.2025.1539629</relationtype>
    <rights>info:eu-repo/semantics/openAccess</rights>
    <rightsUri>https://creativecommons.org/licenses/by-nc-nd/2.5/ar/</rightsUri>
    <subject>TRYPANOSOMA CRUZI</subject>
    <subject>REPOSICIONAMIENTO DE FÁRMACOS</subject>
    <subject>ENFERMEDAD DE CHAGAS</subject>
    <subject>COMPUESTOS TRIPANOCIDAS</subject>
    <subject>ENFERMEDAD DE CHAGAS</subject>
    <title>Datos correspondientes a la publicación "The potential of the antifungal nystatin to be repurposed to fight the protozoan Trypanosoma cruzi"</title>
    <type>dataset</type>
</dataset>
